SAMLYN CAPITAL LLC 13D and 13G filings for Inozyme Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 1:59 pm Sale | 2024-12-31 | 13G | Inozyme Pharma, Inc. INZY | SAMLYN CAPITAL LLC | 0 0.000% | -3,372,558 (Position Closed) | Filing |
| 2024-02-14 1:40 pm Purchase | 2023-12-31 | 13G | Inozyme Pharma, Inc. INZY | SAMLYN CAPITAL LLC | 3,372,558 5.500% | 3,372,558 (New Position) | Filing |